{
    "clinical_study": {
        "@rank": "97648", 
        "brief_summary": {
            "textblock": "This study will assess whether individuals treated with sertraline (Zoloft) and cognitive\n      behavior therapy will experience improvement with their depression and consume less alcohol\n      than individuals treated with a placebo and cognitive behavior therapy.  This is a 12-week,\n      random assignment, placebo-controlled, double-blind study with followup assessments 1 and 3\n      months after treatment."
        }, 
        "brief_title": "Sertraline and Cognitive Therapy in Depressed Alcoholics", 
        "completion_date": "January 2002", 
        "condition": [
            "Alcoholism", 
            "Depression"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Alcoholism", 
                "Depression", 
                "Depressive Disorder"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Meets criteria for major depressive episode.\n\n          -  Meets criteria for alcohol abuse or dependence thirty days prior to entering the\n             study.\n\n          -  Has had no more than one previous inpatient medical detoxification.\n\n          -  Able to maintain sobriety for ten days.\n\n          -  Able to read and understand questionnaires and informed consent.\n\n          -  Lives within 50 miles of the study site, has a stable living situation, and a\n             reliable source of collateral reporting.\n\n        Exclusion Criteria:\n\n          -  Meets criteria for any other psychoactive substance dependence other than nicotine.\n\n          -  Any psychoactive substance abuse (other than nicotine or marijuana) within 30 days\n             before beginning of study.\n\n          -  Meets criteria for other psychiatric disorders including: panic disorder,\n             obsessive-compulsive disorder, bipolar affective disorder, cyclothymia,\n             schizophrenia, any organic mental disorder, eating disorder, dissociative disorder,\n             or post-traumatic stress disorder.\n\n          -  Has evidence of treatment resistant depression defined as more than one previous\n             treatment episode for depression, which can include hospitalization and/or one course\n             of antidepressant medication.\n\n          -  Patients may not have been prescribed a specific serotonergic medication within the\n             month prior to study and may not have taken any antidepressant or antipsychotic\n             within the two weeks prior to study.\n\n          -  Current use of disulfiram (Antabuse) or anti-seizure medications.\n\n          -  Clinically significant medical problems: cardiovascular, renal, gastrointestinal, or\n             endocrine problems that would limit participation or limit medication ingestion.\n\n          -  Hepatocellular disease.\n\n          -  Females who are pregnant, nursing, or not using a reliable form of birth control.\n\n          -  Current charges pending for violent crime (excluding DUI related offenses).\n\n          -  Previous adverse experience with a serotonin reuptake inhibitor.\n\n          -  Current homicidal or suicidal ideation."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "100", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000458", 
            "org_study_id": "NIAAAMOA10476"
        }, 
        "intervention": [
            {
                "intervention_name": "sertraline (Zoloft)", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "cognitive behavior therapy", 
                "intervention_type": "Behavioral"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Sertraline"
        }, 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "Charleston", 
                    "country": "United States", 
                    "state": "South Carolina", 
                    "zip": "29425"
                }, 
                "name": "Medical University of South Carolina"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Sertraline and Cognitive Therapy in Depressed Alcoholics", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000458"
        }, 
        "source": "National Institute on Alcohol Abuse and Alcoholism (NIAAA)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute on Alcohol Abuse and Alcoholism (NIAAA)", 
                "agency_class": "NIH"
            }
        }, 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2002"
    }, 
    "geocoordinates": {
        "Medical University of South Carolina": "32.777 -79.931"
    }
}